Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
13.89
-0.17 (-1.21%)
Sep 17, 2025, 4:00 PM EDT - Market closed
Edgewise Therapeutics Employees
Edgewise Therapeutics had 110 employees as of December 31, 2024. The number of employees increased by 22 or 25.00% compared to the previous year.
Employees
110
Change (1Y)
22
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$1,370,036
Market Cap
1.46B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 110 | 22 | 25.00% |
| Dec 31, 2023 | 88 | 29 | 49.15% |
| Dec 31, 2022 | 59 | 28 | 90.32% |
| Dec 31, 2021 | 31 | 12 | 63.16% |
| Dec 31, 2020 | 19 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EWTX News
- 14 days ago - Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - PRNewsWire
- 4 weeks ago - Edgewise Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewsWire
- 5 weeks ago - Edgewise Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights - PRNewsWire
- 2 months ago - EWTX Investors Have Opportunity to Join Edgewise Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Business Wire
- 2 months ago - Edgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular Dystrophies - PRNewsWire
- 3 months ago - Edgewise Therapeutics to Present at the Annual Goldman Sachs Global Healthcare Conference - PRNewsWire
- 4 months ago - Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 20, 2025 - PRNewsWire
- 4 months ago - Edgewise Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights - PRNewsWire